Levitas Group was proud to take part in The Longevity Show 2026, the UK’s first major consumer longevity festival, held at Tobacco Dock, London.
Bringing together over 150 global experts, the event combined a public exhibition with a business conference, creating a platform for clinicians, researchers, innovators, founders, and the public to explore the future of healthy ageing, preventative medicine, and human optimisation.
Dr Ash Kapoor, Founder of Levitas Clinic, contributed to two key panel discussions during the event. On the Headliner Stage, he joined the session “How to Choose a Longevity Clinic That Works,” which explored how individuals can assess longevity clinics, understand diagnostics and therapies, and identify the importance of clinical oversight when beginning their health optimisation journey. Later, on the Business Stage, Dr Kapoor joined the forward-looking panel “The Longevity Clinic of 2035.” This session examined how AI, emerging technologies, and new clinical models may shape the future of longevity medicine, with discussion around the evolution of personalised, proactive, and data-informed care.
The event also featured a roundtable moderated by Dr Federico Fedel, Medical Co-Director of Levitas Group, titled “Brain Health Optimisation and Psychedelic Updates.” The discussion focused on the growing relevance of brain health, mental resilience, and psychedelic medicine within the wider field of longevity and preventative care.
Levitas Group would like to thank Phil Newman, Co-founder and CEO of Longevity Technology, and the organising team for the invitation to contribute to such an important event.
Our participation at The Longevity Show 2026 reflects Levitas Group’s continued commitment to advancing the conversation around longevity medicine, health optimisation, and evidence-informed approaches that support longer, healthier, and more resilient lives.
